Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liquid biopsies in gastrointestinal malignancies: when is the big day?
Lopez A, Harada K, Mizrak Kaya D, Dong X, Song S, Ajani JA. Lopez A, et al. Among authors: mizrak kaya d. Expert Rev Anticancer Ther. 2018 Jan;18(1):19-38. doi: 10.1080/14737140.2018.1403320. Epub 2017 Dec 4. Expert Rev Anticancer Ther. 2018. PMID: 29202614 Review.
Translating genomic profiling to gastrointestinal cancer treatment.
Harada K, Mizrak Kaya D, Shimodaira Y, Song S, Baba H, Ajani JA. Harada K, et al. Among authors: mizrak kaya d. Future Oncol. 2017 Apr;13(10):919-934. doi: 10.2217/fon-2016-0422. Epub 2017 Jan 9. Future Oncol. 2017. PMID: 28067073 Free PMC article. Review.
Potentially Curable Cancers of the Esophagus and Stomach.
Elimova E, Mizrak Kaya D, Harada K, Ajani JA. Elimova E, et al. Among authors: mizrak kaya d. Mayo Clin Proc. 2016 Sep;91(9):1307-18. doi: 10.1016/j.mayocp.2016.07.018. Mayo Clin Proc. 2016. PMID: 27594190 Free PMC article. Review.
Advanced gastric adenocarcinoma: optimizing therapy options.
Mizrak Kaya D, Harada K, Shimodaira Y, Amlashi FG, Lin Q, Ajani JA. Mizrak Kaya D, et al. Expert Rev Clin Pharmacol. 2017 Mar;10(3):263-271. doi: 10.1080/17512433.2017.1279969. Epub 2017 Feb 3. Expert Rev Clin Pharmacol. 2017. PMID: 28094573 Review.
Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.
Mizrak Kaya D, Dong X, Nogueras-González GM, Xu Y, Estrella JS, Harada K, Lopez A, Amlashi FG, Hofstetter WL, Maru DM, Nguyen QN, Lee JH, Weston B, Bhutani MS, Erasmus JJ, Thomas I, Rogers JE, Song S, Ajani JA. Mizrak Kaya D, et al. Med Oncol. 2017 Aug;34(8):135. doi: 10.1007/s12032-017-0994-2. Epub 2017 Jul 6. Med Oncol. 2017. PMID: 28685276
Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial.
Harada K, Wang X, Shimodaira Y, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Lopez A, Blum Murphy MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Harada K, et al. Among authors: mizrak kaya d. Target Oncol. 2018 Feb;13(1):99-106. doi: 10.1007/s11523-017-0540-3. Target Oncol. 2018. PMID: 29218623 Free PMC article. Clinical Trial.
24 results